KRMN
The market finally blinked
Karman Holdings just got a fresh Buy upgrade after the stock had already been absolutely put through the wringer, down 68%. The bull case is pretty straightforward: Q2 was solid, organic growth hit 24%, backlog hit a record $1.3 billion, and management lifted 2026 revenue and EBITDA guidance. Translation: there’s more line-of-sight on the next couple of years than the market seemed to be pricing in.
Why investors are paying attention
This is the kind of setup that can make a stock go from "what even is this?" to "okay, maybe we should talk about this again." Better 2027 revenue visibility matters because markets love predictability almost as much as they hate surprises. A growing backlog and raised guidance suggest demand isn’t just a one-quarter sugar high.
The fine print is still messy
- Free cash flow is still weak, so the company isn’t exactly minting cash like a startup in its “we have no moat” era.
- Leverage is elevated, which means the balance sheet isn’t giving anyone warm fuzzies.
- Internal control issues are still unresolved, and that’s never the kind of phrase investors want to hear in a confidence-boosting story.
- A recent CFO transition adds another layer of “please don’t make me do extra homework.”
Big picture
The upgrade says Karman may have more real operating momentum than its battered share price suggests. But with execution risks still hanging over the name, this is less “mission accomplished” and more “the rocket launched, but the pre-flight checklist still isn’t fully closed.”